News News Select Year All Years 2026 (23) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 495 Results Page 48 of 50« First«...102030...4647484950» June 18, 2012 Positive interim clinical data in peanut allergic children treated with VIASKIN PEANUT June 6, 2012 DBV Technologies’ June 6th 2012 Ordinary Meeting of Shareholders May 31, 2012 Professor Hugh Sampson joins Scientific Advisory Board of DBV Technologies May 15, 2012 First quarter 2012 topline, scientific activity and upcoming clinical data May 10, 2012 DBV Technologies welcomes Charles Ruban as Chief Development Officer March 28, 2012 Successful Initial Public Offering (IPO) for DBV Technologies February 28, 2012 Viaskin Peanut receives FDA “Fast Track Designation” January 31, 2012 DBV Technologies announces the filing of its “Document de Base” with the French Autorité des marchés financiers December 6, 2011 DBV Technologies introduces its new Chief Financial Officer September 21, 2011 DBV Technologies moves to Bagneux Page 48 of 50« First«...102030...4647484950»